Early Symptoms of Hypertension:
Identifying Patterns
with HUAWEI’s Blood Pressure Smartwatch
Reading duration: Approximately 6 minutes
Professor Fabio Angeli
Professor Fabio Angeli, esteemed Chair of the Bachelor of Science in Nursing and a renowned Professor of Cardiology at the University of Insubria in Varese, Italy, leads the General Internal Medicine and Rehabilitation Cardiology units at ICS Maugeri in Tradate. Recognized as one of the top 0.1% of hypertension scholars by Expertscape, he has authored over 300 scientific publications in prestigious journals, including The Lancet and JACC.
In this article
Rethinking Hypertension: The Urgent Need to Enhance Detection and Control
HUAWEI WATCH D2 and HUAWEI WATCH D: Certified Health Monitoring
Daily Life Use and Detection of Masked Hypertension
Conclusion
To recognize these potential risks early or to avoid them altogether, it is advisable to measure your blood pressure regularly, even at a young age. But let's be honest—how many of us actually have a blood pressure monitor at home and only use it as precaution? Most people don't think about their blood pressure until there's a problem.
Rethinking Hypertension: The Urgent Need to Enhance Detection and Control
Much concern has been raised by recent guidelines [1-3] on the diagnosis and management of
hypertension about the need for a fresh focus on hypertension recognition, and the need to
revitalize hypertension control efforts [3]. This is critical because untreated hypertension can
lead to severe health issues, such as:
o Coronary artery disease (CAD)
o Heart attack (myocardial infarction)
o Stroke
o Heart failure
o Peripheral artery disease (PAD)
o Aneurysm
o Hypertension-related heart disease
o Kidney diseases
Indeed, in the last years the intensity has relaxed for the
identification of new patients with high blood pressure, and for the necessity to maintain blood
pressure control during
antihypertensive treatment [4]. This is particularly critical
because many individuals with high blood pressure do not always experience symptoms. When
symptoms do occur, they may
include:
o Headaches
o Dizziness
o Difficulty breathing
o Nausea
o Vomiting
o Blurred or altered vision
o Anxiety
To recognize these potential risks early or to avoid them altogether, it is advisable to measure your blood pressure regularly, even at a young age. But let's be honest—how many of us actually have a blood pressure monitor at home and only use it as precaution? Most people don't think about their blood pressure until there's a problem.
HUAWEI WATCH D2 and HUAWEI WATCH D: Certified Health Monitoring
However, the advent of new technologies in smartwatches has opened up new possibilities for measuring blood pressure that go beyond traditional measurements. Devices such as the HUAWEI
WATCH D series give us the
opportunity to monitor home blood pressure and to test whether these symptoms are associated
with excessively elevated or low blood pressure values.
Other emerging technologies include wearable, wrist-based blood pressure measurement devices, devices evaluating central blood pressure, and cuffless devices implementing plethysmographic or other technologies.
As studies have shown, the blood pressure readings taken by the
HUAWEI
WATCH
D are not only comparable to those obtained from a
reference sphygmomanometer, but are also consistent and accurate when measured against the
gold standard clinical sphygmomanometer [5-8]. Moreover, thanks to its dual-use functionality, the HUAWEI WATCH D and its successor, the HUAWEI
WATCH
D2 can be comfortably worn all day, facilitating long-term
monitoring and enabling the detection of both asymptomatic and symptomatic high blood
pressure.
The HUAWEI WATCH D combines the
functions of an advanced
smartwatch with the ability to monitor our health status, including the monitoring of
blood
pressure, electrocardiogram heart rate, SpO2, stress, and skin temperature.
Notably, it has been validated for use according to international protocols, most notably the CE certification in EU countries [5-8]. The second generation, the HUAWEI WATCH D2, is an evolution of the HUAWEI WATCH D, also a cuff-based blood pressure smartwatch CE medical certification., with the additional feature of ambulatory blood pressure monitoring (ABPM).
The HUAWEI WATCH D2 uses the same technology for blood pressure measurement as the HUAWEI WATCH D, which has been validated for medically certified according to international protocols [6-9]. In fact, the blood pressure values measured by the HUAWEI smartwatch were comparable to the reference blood pressure of a traditional blood pressure monitor by sphygmomanometer [5-8].The measurement is carried out by an integrated miniature pump and an inflatable cuff in the wristband, which precisely measures the blood pressure on the wrist.
The HUAWEI WATCH D combines the
functions of an advanced
smartwatch with the ability to monitor our health status, including the monitoring of
blood
pressure, electrocardiogram heart rate, SpO2, stress, and skin temperature.
Notably, it has been validated for use according to international protocols, most notably the CE certification in EU countries [5-8]. The second generation, the HUAWEI WATCH D2, is an evolution of the HUAWEI WATCH D, also a cuff-based blood pressure smartwatch CE medical certification., with the additional feature of ambulatory blood pressure monitoring (ABPM).
The HUAWEI WATCH D2 uses the same technology for blood pressure measurement as the WATCH D, which has been validated for medically certified according to international protocols [6-9]. In fact, the blood pressure values measured by the HUAWEI smartwatch were comparable to the reference blood pressure of a traditional blood pressure monitor by sphygmomanometer [5-8].The measurement is carried out by an integrated miniature pump and an inflatable cuff in the wristband, which precisely measures the blood pressure on the wrist.
a. Monitoring Blood Pressure at Home with HUAWEI WATCH D2 and HUAWEI WATCH D
HUAWEI WATCH D2
Ambulatory Blood Pressure Monitoring Precisely manage your health every moment
All-round Health Management
Light and Slim Design
Smart Living Experience Bluetooth calling, music playback and more
Medically Certified
Compatible with iOS and Android
Monitoring Blood Pressure at Home with HUAWEI WATCH D2 and HUAWEI WATCH D
It is now out of the question that home blood pressure is a highly valuable clinical tool, and its use is constantly growing [9,10]. It is also well-documented that home blood pressure received over the past 2 or 3 decades a greater bulk of data supporting its use to refine the grading of patients into risk levels and, in general, the management of the hypertensive patient [9,10].
Daily Life Use and Detection of Masked Hypertension
I had the opportunity to try this device during usual daily life. The use of
this
device is very simple, and it shows that individuals may care more about blood
pressure monitoring accuracy, with better compliance. Using the HUAWEI Health App, the HUAWEI WATCH D2 and D
computes mean blood pressure and mean heart rate, choosing a time span ranging from 1 day to 1
month.
The HUAWEI
WATCH
D
also offers the opportunity to detect masked hypertension [11-14]. Masked hypertension
detection
involves monitoring blood pressure outside of a clinical setting, often using home blood pressure
monitors or wearable devices that track readings throughout the day in various environments.
The new function of the HUAWEI WATCH D2 offers continuous measurements (with the option of setting 15-, 20-, 30-, 45- and 60-minute intervals) over 24 hours, including day and night. The user can now set whether the watch measures blood pressure automatically or not. Notably, using its specific app, (HUAWEI Health APP) the HUAWEI WATCH D2 generates specific reports including all these components of ambulatory blood pressure.
Masked hypertension is a condition where an individual's blood pressure appears normal during a medical check-up at the doctor's office but becomes elevated at home or in other environments. This discrepancy can often go unnoticed during routine visits, posing a higher risk for cardiovascular diseases. It affects approximately 1 in 7-8 individuals who have normal readings in a clinic or doctor's office.
Meta-analysis [11]of longitudinal studies that addressed the
prognostic impact of masked hypertension diagnosed by ambulatory blood pressure and
self-measured blood pressure(when compared with normotension)
Most importantly, subjects with masked hypertension show a 1.5x to 3x higher risk of major
cardiovascular disease than those with normal
blood pressure [11-14]. Several factors have been identified as possible
contributors to masked
hypertension:
o Psychological stress
o Physical activity
o Cigarette smoking
o Alcohol
o Work-related stress
The HUAWEI WATCH D2 is recommended for personal use across a wider population and potentially offers opportunities to drive precision medicine
Moreover, the HUAWEI WATCH D2 may be a useful device to detect masked hypertension among subjects who appear to be more likely to have this condition, and encourage users to seek advice from a medical professional. It is now well established that ambulatory blood pressure monitoring (ABPM) can paint the rest of the picture about the real blood pressure load and variability of a person over a 24-hour period. Tillhe ambulatory blood pressure monitoring (ABPM) function of the second generation of the smartwatch offers greater prognostic value than single office readings for doctors, as it provides data which enables me to obtain a more comprehensive assessment of cardiovascular risk [16].
Conclusion:
In conclusion, the HUAWEI WATCH D2 and HUAWEI WATCH D can be recommended for personal use across a wider population [8]. The rich data from blood pressure measurements, along with other health-related parameters recorded by the watch and corresponding app, HUAWEI Health APP, offer greater insight into individual health, and enable healthcare professionals to assist users more adequately in their healthcare journey.
Medical disclaimer:
The HUAWEI WATCH D2, HUAWEI WATCH D and the ECG feature is intended to be used by people aged 18 years and over, but
is
not intended to replace any medical diagnosis or treatment. Data obtained during the use of this
device
and feature is for personal reference only. Before using the device, please carefully read the Quick
Start Guide, Wearing Guide, and Instruction for Use.
Due to national restrictions on obtaining approval / registration as a medical device, the HUAWEI WATCH D2 and HUAWEI WATCH D and will only be available in selected European markets, and the ECG feature only works on watches
and
smartphones purchased in countries where the service is available.
- Supported smartphones: Mobile phones with Android 6.0 or compatibles, HarmonyOS 2.0 or
compatibles, or
iOS 12.0 or compatibles. The Huawei Health app version on your mobile phone must be 11.0 or
compatibles.
Please make sure that your wearable device and phone are running the latest versions before using
ECG.
Heart rate, SpO2, stress and skin temperature are not medical device features, monitoring data and
results are for reference only and should not be used as a basis for medical diagnosis or
treatment.
[References]
- 1. Angeli, F.; Reboldi, G.; Trapasso, M.; Gentile, G.; Pinzagli, M.G.; Aita, A.; Verdecchia, P. European and US guidelines for arterial hypertension: similarities and differences. Eur J Intern Med 2019, 63, 3-8, doi:10.1016/j.ejim.2019.01.016.
- 2. Verdecchia, P.; Angeli, F.; Reboldi, G. Should we rethink the blood pressure targets in hypertension guidelines? Blood Press Monit 2022, 27, e7, doi:10.1097/01.mbp.0000905216.32172.43.
- 3. Verdecchia, P.; Cavallini, C.; Angeli, F. Advances in the Treatment Strategies in Hypertension: Present and Future. J Cardiovasc Dev Dis 2022, 9, doi:10.3390/jcdd9030072.
- 4. Angeli, F. New Perspectives and Strategies for the Management of Hypertension. J Cardiovasc Dev Dis 2023, 10, doi:10.3390/jcdd10080346.
- 5. Wang, L.; Xian, H.; Guo, J.; Li, W.; Wang, J.; Chen, Q.; Fu, X.; Li, H.; Chen, Q.; Zhang, W.; et al. A novel blood pressure monitoring technique by smart HUAWEI WATCH: A validation study according to the ANSI/AAMI/ISO 81060-2:2018 guidelines. Front Cardiovasc Med 2022, 9, 923655, doi:10.3389/fcvm.2022.923655.
- 6. Yi, L.; Lv, Z.H.; Hu, S.Y.; Liu, Y.Q.; Yan, J.B.; Zhang, H.; Li, H.B.; Chen, Q.; Li, Y.Y.; Jiang, Y.F.; et al. Validating the accuracy of a multifunctional smartwatch sphygmomanometer to monitor blood pressure. J Geriatr Cardiol 2022, 19, 843-852, doi:10.11909/j.issn.1671-5411.2022.11.004.
- 7. Zhang, W.; Zhou, Y.N.; Zhou, Y.; Wang, J.G. Validation of the watch-type HUAWEI WATCH D oscillometric wrist blood pressure monitor in adult Chinese. Blood Press Monit 2022, 27, 353-356, doi:10.1097/MBP.0000000000000608.
- 8. Lee, W.L.; Danaee, M.; Abdullah, A.; Wong, L.P. Is the Blood Pressure-Enabled Smartwatch Ready to Drive Precision Medicine? Supporting Findings From a Validation Study. Cardiol Res 2023, 14, 437-445, doi:10.14740/cr1569.
- 9. Angeli, F.; Reboldi, G.; Verdecchia, P. Home blood pressure and treatment decisions: caveat emptor. J Hypertens 2016, 34, 1494-1496, doi:10.1097/HJH.0000000000000999.
- 10. Verdecchia, P.; Angeli, F.; Notaristefano, F.; Reboldi, G. How Low Should We Go With Home
Blood
Pressure in Elderly Patients With Atrial Fibrillation?
Hypertension 2022, 79, 2706-2707, doi:10.1161/HYPERTENSIONAHA.122.20337. - 11. Angeli, F.; Reboldi, G.; Verdecchia, P. Masked hypertension: evaluation, prognosis, and treatment. Am J Hypertens 2010, 23, 941-948, doi:10.1038/ajh.2010.112.
- 12. Angeli, F.; Reboldi, G.; Verdecchia, P. Masked Nocturnal Hypertension: A Complex Phenomenon to Detect in Clinical Practice. Am J Hypertens 2021, 34, 578-580, doi:10.1093/ajh/hpab007.
- 13. Verdecchia, P.; Angeli, F.; Gattobigio, R.; Borgioni, C.; Castellani, C.; Sardone, M.; Reboldi, G. The clinical significance of white-coat and masked hypertension. Blood Press Monit 2007, 12, 387-389, doi:10.1097/MBP.0b013e32824958e5.
- 14. Verdecchia, P.; Angeli, F.; Reboldi, G. Masked and White-Coat Hypertension: Moving to African Americans. J Am Coll Cardiol 2015, 66, 2170-2172, doi:10.1016/j.jacc.2015.09.008.
- 15. Franklin, S.; O’Brien, E.; Staessen, J. A. Masked hypertension: understanding its complexity. European Heart Journal 2017, 38, 1112-1118, doi:10.1093/eurheartj/ehw502.
- 16. Angeli, F,; Reboldi, G.; Solano, F.G.; Prosciutto, A.; Paolini, A.; Zappa, M.; Bartolini, C.;, Santucci, A.; Coiro, S.; Verdecchia, P. Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The ‘Ambulatory Does Prediction Valid (ADPV)’ Approach. Diagnostics 2023, 13(9), 1601, https://doi.org/10.3390/diagnostics13091601
Administrator
Copied